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It is well-known that group testing is an efficient strategy to screen for the 
presence of a virus. It consists of pooling n individual samples with a single 
test using RT-PCR. If no individual in the group is infected, the group test is 
negative. Thus, a single test may reveal this crucial information. We show how 
group testing can be optimised in three applications to multiply the power of 
tests against Covid-19: Estimating virus prevalence to measure the evolution 
of the pandemic, bringing negative groups back to work to exit the current 
lockdown, and testing for individual infectious status to treat sick people. 
For an infection level around 2%, group testing could multiply the power of 
testing by a factor of 20. The implementation of this strategy in the short run 
requires limited investments and could bypass the current immense shortage 
of testing capacity.
1. Introduction
As the coronavirus pandemic develops, governments around the world have 
now reacted and imposed lockdowns in many countries. Since India imposed 
strict lockdown restrictions on more than 1.3 billion residents, the total world 
population under lockdown is now around three billion. By stopping many 
production processes, the economic cost of the lockdown is very large. For 
example, Thunstrom et al. (2020) estimate the cost of the lockdown in the US at 
$7.2 trillion. Finding a way forward is a critical issue. No doubt that the decision 
to unlock people in the next few weeks or months will be a complex political, 
1 The  authors  are  grateful  to  Marija Backovic, John  Cochrane,  Romain  Gérémi,  Mélanie  Gollier,  Julie 
Harou, Margarita Kirneva, Larry Kotlikoff, Michael Kotlikoff, Marc M´ezard, Vincent Rollet, David Sraer, 
Stephane Straub, and Charlotte Wiatroweski as well as participants to the USC workshop “The Economics of 
the Covid-19 Crisis” for useful comments.
2 Director, Toulouse School of Economics and Professor of Economics, University of Toulouse-Capitole.
3 Director of Research, CNRS — CREST and Professor, Ecole polytechnique and London School of Economics.
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health, social, and economic issue. A major risk exists that once the pandemic 
slows down or appears to be under control and lockdown measures are lifted, 
new waves of Covid-19 reappear. The 20th century has known three influenza 
pandemics: the 1918 ‘Spanish flu’, the 1957 ‘Asian flu’, and the 1968 H3N2 ‘Hong 
Kong flu’. The 21st century has already witnessed the 2009 ‘Swine Flu’. These 
four pandemics came in waves, with subsequent waves being more deadly than 
the first (Miller et al. 2009).
Therefore, a key element to reduce the economic consequences of Covid-19 
is the ability to test individuals, given the large prevalence of asymptomatic 
but highly contagious people in the population. Massive testing is necessary 
to monitor the prevalence of the virus in the population in different times and 
geographical areas. It is also a necessary component to detect infected individuals, 
quarantine them, and provide medical treatment whenever necessary. Moreover, 
mass reliable testing would bring back people who have tested negative to work 
in strategic sectors of the economy, without risking a second wave of contagion. 
As shown by the experience of South Korea, mass testing is crucial to control the 
pandemic. As stated by Dewatripont et al. (2020), “restarting production in the 
economy requires the reliable identification of individuals who will not contract 
the virus or transmit it to others, whether they have previously displayed the 
associated symptoms or not.”
The standard method for testing for the presence of Covid-19 in a sample 
is called Real-Time Polymerase Chain Reaction (RT-PCR), which involves a 
chemical reaction that produces fluorescent light if viral DNA is present. Testing 
involves two steps - first taking samples from individuals, then amplifying parts 
of the virus DNA known as markers through a PCR machine. The first step is 
relatively cheap, but the second one is the bottleneck that limits our testing 
capacities. Scaling up the capacity of RT-PCR testing for the SARS-COV-2 virus 
responsible for Covid-19 will take time. It reduces our expectation of a rapid exit 
from the current lockdown strategy. The US is currently scaling up production up 
to 1.2 million per week (for a population of 330 million), Germany is producing 
500,000 tests per week (population 84 million) and France is producing a mere 
84,000 tests per week, scaling up to 210,000 per week in April (population 65 
million). Current test production levels are insufficient for mass testing in these 
countries, not to mention the huge need for tests in developing countries. Each 
Covid-19 test has to be viewed as a precious resource, to be utilised as efficiently 
as possible.
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In this paper, we exploit a standard testing methodology in which individual 
samples are pooled.4 This pooled sample is then tested with a single test. If the 
test of the combined sample is negative, then all individuals in the group are 
known to be virus-free, a highly valuable information if the size of the group is 
large. The implementation of this methodology at the Technion University for 
Covid-19 suggests that the dilution effect of pooling individual samples is very 
limited.5 While individual testing determines whether a given person is a carrier 
of the virus, group testing will determine whether the virus is present in the 
group sample or not. Therefore, group testing will be able to reach one of two 
conclusions: a negative outcome will indicate that none of the individuals of the 
group is a carrier of the virus, while a positive outcome will indicate that at least 
one individual in the group is a virus carrier, without any further information 
on the identity of this person. The optimisation of the group testing strategy 
depends upon the objective pursued by the test. In this paper, we examine three 
highly relevant objectives in the context of the Covid-19 pandemic, and we 
characterise efficient detection strategies to attain them.
2. Applications of group testing
Group testing is not a new idea. It originated in Dorfman (1943) in the context 
of syphilis detection, but it has also been applied in the case of hepatitis B, avian 
pneumovirus, and HIV (see for example May et al. 2010). A more advanced 
mathematical theory of group testing can be found for instance in Mézard et 
al. (2007) and Mézard et al. (2011). A recent survey is Aldridge et al. (2019). 
Our paper illustrates three applications of this theory to the problem of fighting 
Covid-19 in the coming weeks. Group testing can be used for the same purposes 
as individual testing. However, the protocol needs to be adapted to the situation. 
We detail below practical applications of group testing and discuss its efficiency 
in comparison with individual testing.
As we write this article, group testing for Covid-19 has already been 
implemented in Nebraska6 and in Israel.
4 See also Jain and Jain (2020).
5 PCR was able to detect the presence of the virus in a pooled sample from 64 individuals with a single infected 
person. See https://www.technion.ac.il/en/2020/03/pooling-method-for-accelerated-testing-of-Covid-19/ . A 
team at the University of Frankfurt came to a similar conclusion: https://aktuelles.uni-frankfurt.de/englisch/
pool-testing-of-sars-cov-02-samples-increases-worldwide-test-capacities-many-times-over/.
6 https://www.3newsnow.com/news/coronavirus/live-gov-ricketts-provides-coronavirus-briefing-3-24-20 
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3. Prevalence estimation
There is widespread discussion about the prevalence of the virus in different 
populations. This information is of crucial importance and will impact policy in 
many cases. In particular, it allows close monitoring of the spread of the disease. 
It becomes possible to estimate the ratio of critical cases over total number of 
cases, as well as the fatality rate, and it allows identification of  geographical 
zones with high infection levels. 
The main reason why the information is not well known is the limited 
availability of tests. Typically, a testing method would involve randomly 
sampling and testing a group in the population. Relying on hospital admissions 
is not satisfactory as many cases are either asymptomatic or symptoms are mild 
enough to recommend prolonged confinement without testing. Here we show 
how group testing leads to more accurate results with a fewer number of tests 
(see also Pritchard and Tebbs 2011). 
We compare two methods for estimating the prevalence of the virus in the 
population: (i) individual testing, in which a sample of 12,000 people are tested 
for the virus, and a standard binomial test is applied to derive a 95% confidence 
interval, and (ii) group testing, in which 500 groups of 35 people are tested (total 
population involved 17,500).
3.1 Individual testing
Assume that 2% of people in the sample are infected, returning 240 positive 
tests.7 A standard binomial test re- turns the following 95% confidence interval 
on the infected population:
CI
IT
 = [1.76%, 2.27%].
3.2 Group testing
Assume again that 2% of individuals in the sampled population are infected, 
and that individuals are allocated to groups randomly for testing. For each group 
of 35, there is a probability of 1 – (1 – 0.02)35 c 50.7% that it contains at least 
one infected person, meaning the test returns positive. This corresponds to 253 
group tests returning positive, and 247 returning negative. With such data, the 
95% confidence interval on the proportion of groups of 35 in the population 
7 For simplification, the tests are assumed in these applications to return no false positives or negatives. 
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containing at least one infected person is: [46.1%, 55.1%]. The corresponding 
confidence interval on the underlying proportion of infected people in the 
population is:8
CI
GT
 = [1.75%, 2.26%].
3.3 Comparison of results
Both group testing and individual testing return the same point estimate on the 
proportion of infected individuals (2%). They return slightly different confidence 
intervals due to a non-linearity in the formulas involved. Both confidence 
intervals have the same size of 0.5%, which is a reasonable size on which policy 
making decisions can be based. However, the cost in terms of number of tests is 
drastically lower for group testing (500) compared to individual testing (12,000). 
In this application, group testing allows to economise on tests by a factor of 24.
Note that group size 35 is optimised so that each group test positive with 
probability circa 0.5 for 2% prevalence. In principle, prevalence is not known, 
so group size may not be chosen optimally. This will lead to a slightly degraded 
performance of group testing. In this application, group testing allows to 
economise on tests by a factor 24 while keeping groups of reasonable size.
3.4 Optimal group size
Given a prevalence level p and a number of groups, the variance estimator is 
minimized for a group size such that the probability q that a group of size n is 
tested positive satisfies q c −ln(1 − q)/2, which gives q c 0.80, and n ln .2
ln (1–p)
c .9 
For a prevalence of 2%, groups of size 80 are optimal from the statistical point 
of view. In practice, technical limitations as well as the cost of collection of 
individual samples put a downwards pressure on group size.
4. A plan to exit the lockdown
Building testing capacity will take time, even with a wartime mobilisation of 
means. We therefore propose to complement this investment plan with an 
immediate expansion of the testing capacity by using group testing. Contrary to 
Dorfman (1943), we don’t attempt in this section to identify infected individuals. 
We rather determine the size of group testing that maximises the number of 
individuals whose testing demonstrates they are not infected. The scarcity of 
tests obviously means that it is better to use a test to detect the virus in another 
8 The confidence interval on proportion of infected people is given by [1 – (1 – .455)35
1
, [1 – (1 – .455)35
1
].
9 The authors are grateful to Xavier d’Hautfeuille for this insight.
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untested group than to try to discover who is infected in a positive group. This is 
because the value of information from the test does not come from the treatment 
of infected people in the absence of an efficient drug to do that. In the context of 
Covid-19, the value of the test rather comes from sending healthy people back to 
work as soon as possible, without risking infection.
Suppose that the prevalence rate of the virus in the target population is p. The 
testing capacity is assumed to be very limited in the sense that even group testing 
will not allow for testing the entire population. We assume that when a group is 
detected with the virus, their members remain confined. Let n denote the size of 
the groups to be tested. If n is too large, too many groups will be detected with 
the virus, and that will reduce the expected number of people who will be allowed 
to get back to work. Technically, the frequency of groups tested negative is equal 
to (1 – p)n, so that the expected number of people freed from confinement with a 
single test is equal to n(1 – p)n. The optimal size of group testing maximises this 
function of n. It satisfies the following first-order condition:
n =
−1
log(1− p)
≈
1
p
.
 
(1)
The optimal size of the group is decreasing with the prevalence ratio. It 
is optimal that the group size be approximately equal to the inverse of the 
prevalence ratio. The above equation gives us the following expected number N 
of people back to work with a single test:
N =
(1− p)
−1
log(1−p)
− log(1− p)
.
 
(2)
The expected number of people freed from confinement with a single test is 
decreasing in the prevalence ratio. The individual testing strategy with one test 
allows for freeing an expected number of people equalling 1 – p. We obtain that 
the power of the group testing strategy over the individual testing strategy is 
equal to
P =
(1− p)
−1
log(1−p)
−1
− log(1− p)
.
 
(3)
This means that the optimal group testing strategy frees in expectation P times 
more people from the lockdown than when using the individual testing strategy.
We can also value the benefit of increasing the testing capacity. To do this, we 
need to measure the social cost q of individual confinement. Suppose that the 
optimal confinement strategy in the absence of testing is to remain idle for two 
months. Therefore, we can assume that this social cost equals two months of 
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GDP per capita. For the EU whose GDP per capita is approximately €31,000 
per annum, this corresponds to q = €5,167. The social value of each test is thus 
equal qN.
4.1 Individual testing
Suppose for example that the prevalence ratio is 2%. Each individual has 98% 
chances of not being infected and released after testing. Each test allows the 
release of 0.98 people on average. The value of a single test is thus equal to 
€5,063.
4.2 Group testing
Consider testing groups of n = 50 people. Each test returns negative if everyone 
in the group is healthy, which has probability 0.9850~36%. The average number 
of people each test allows to release is then N = .36 × 50  c18.2. The value of a 
single test is thus equal to €94,077. Although fewer tests are negative with group 
testing, each of them allows to release 50 people back to work. Group testing is 
more efficient than individual testing by a factor P = 18.6.
In Table 1, we describe the characteristics of the optimal strategy for different 
values of the prevalence ratio, taking account of the integer nature of n. We 
assumed that the health status is i.i.d. in the target population. In practice, group 
size must be tailored according to available information on risk prevalence. Also, 
groups of people may be correlated in their risks of being infected.
Prevalence
ratio (p)
Optimal
size (n)
Expected number
deconfined (N )
Power of group
testing (P)
Expected benefit
(qN, in euros)
0.01 99 36.60 36.97 189 129
0.02 49 18.21 18.58 94 083
0.05 19 7.17 7.55 37 046
0.1 9 3.49 3.87 18 016
0.2 4 1.64 2.05 8 466
0.3 3 1.03 1.47 5 317
0.4 2 0.72 1.20 3 720
Table 1 Optimal group testing strategy
Notes: Optimal group testing strategy as a function of the prevalence rate in the target population. We assume that 
q = €5167.
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Testing positively correlated groups and adjusting group size adequately would 
increase performance of the system. People working in the same production 
units, such as production lines or offices, have a high degree of correlation 
in their infectious statuses. Individual workers also have a high degree of 
complementarity. In such situations, it is efficient to test a whole production 
unit as a group and close it when the test returns positive.
5. Testing individuals with group testing
One of the most important applications of testing is to know whether an 
individual is infected. Group testing can allow for a much more efficient way of 
testing each individual in a population than individual testing.
Here we present a protocol for testing whether individuals in a population carry 
the virus, based on sequential group tests. Each individual in the population will 
be marked as positive (‘+’), negative (‘-’), or unknown (‘?’). Initially everyone is 
marked as ‘?’.
Box 1 Testing protocol
T32 Test a group of 32 individuals.
1. If the test is negative, mark all 32 individuals as ‘-‘ and the protocol stops
2. If the test is positive, form two subgroups of 16, tagged 16A and 16B T16
Test the group 16A
1. If 16A is positive, mark everyone in 16B as ‘?’, from 16A create two 
subgroups of 8 individuals, tagged 8A and 8B
2. If 16A is negative, mark everyone in 16A as ‘-‘, from 16B create two 
subgroups of 8 individuals, tagged 8A and 8B
T8 Test the group 8A
1. If 8A is positive, mark everyone in 8B as ‘?’, from 8A create two sub- 
groups of 4 individuals, tagged 4A and 4B
2. If 8A is negative, mark everyone in 8A as ‘-‘, from 8B create two sub- 
groups of 8 individuals tagged 4A and 4B
Proceed until a group of 2 individuals is known to hold at least one virus 
holder.
T1 Test one of the two individuals
1. If the test returns positive, mark this individual ‘+’, the other as ‘?’.
2. If the test returns negative, mark this individual ‘-‘, the other as ‘+’.
The protocol returns the infectious status of individuals marked ‘+’ or ‘-‘. No 
information is known about those marked ‘?’ and these individuals re-enter 
the protocol in newly formed groups of 32.
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Estimation of the protocol efficiency
We estimate the average number of tests for each run of the protocol, as well 
as the average number of individuals for whom the infection status returns 
as known. For simplification we make the approximation that a group of 32 
individuals has probability 50% to contain at least one infected person.
In case the first group is negative, the protocol ends. In case it is positive, it 
runs tests T32, T16, T8, T4, T2, and T1, hence 6 tests. So on average the protocol 
runs 7/2 tests.
If the first test is negative, all 32 people’s status is returned as known. If the 
first test is positive, each test TX (X = 16, 8, 4, 2,1) returns either positive or 
negative with probabilities approximately 1/2. If it returns positive, X people 
exit the protocol with unknown status at this stage; if it returns negative none 
exit with unknown status at this stage. Therefore, the average number of people 
who exit with unknown status is:
1
2
(
1
2
16 +
1
2
8 +
1
2
4 +
1
2
2 +
1
2
1) =
31
4
,
So the number of people returning with known status is on average 32 – 31/4 
= 97/4 .
Each test therefore returns the status of on average of 97
4
/ 7
2
∼ 6.9.
Applying the protocol is tantamount to an increase of test production by a 
factor of almost seven. Even a factor of three would mean a huge scaling up in 
world testing capabilities.
5.1 Two-stage protocols
Note that the sequential protocol may require several swabs for a given individual. 
Given the cost of collecting a swab, including its labour cost, is much smaller than 
the cost of testing a sample, we find this point essentially non-problematic. In 
practice, one should probably amend the protocol in order to have a reasonable 
upper bound on the number of swabs each individual is required to provide.
With only two swabs, both Technion Institute of Technology and Nebraska 
hospitals have started implementing the original algorithm of Dorfman (1943), 
which goes as follows:
• Test a group of n individuals
•  If the test is negative, all n individuals are negative
•  If the test is positive, test each individual separately
With a probability p of each individual of being infected, the average number 
of tests per individual is
Tp(n) =
1 + (1− (1− p)n)n
n
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Given p, we must adjust group size to minimize Tp(n). For p = 2%, we find that 
n = 8 is optimal, using 0.27 tests per individual, thus allowing to find out about 
3.65 individual conditions per test used. For p = 1%, n = 11 is optimal, allowing 
to find out about 5.11 individual conditions per test.
In practice, such a simple algorithm is not optimal, but already allows for very 
significant savings in the number of tests used.
6. Errors and information theory
Abstracting from virus detection, sequential group testing can be viewed as a 
coding problem. The list of infectious status of all individuals in the population 
consists of a message, and a sequence of test results read should be enough to 
recover this message. Information Theory (Shannon 1948, Cover and Thomas 
2006) tells us that a lower bound on the number of tests required per individual 
in the population is:
h/C
where
• C is known as the capacity of the channel and depends on the test accuracy. 
A perfect test returning the infectious status of the patient (positive or 
negative) with no errors has a capacity of 1. Tests with lower accuracy also 
have lower capacities, and 
• h is the entropy per individual in the population. In the case of an i.i.d. 
population with prevalence p, h = H(p) = –p log2(p) (1 – p) log2(1 – p). 
When p = 2%, h ~ 0.112. Assuming a test with no errors, the theoretical 
bound on the number of tests per individual is then 1/0.1414 ~ 7.1, showing 
that the protocol suggested above achieves near-optimality.
7. Conclusion
Testing for Covid-19 is a bottleneck that we face in front of the pandemic. Test 
production is currently much below what is necessary for mass testing strategies 
which are required in order to control the pandemic while letting people go 
back to work. Adequate use of group testing can save many tests, between 85% 
and 95% depending on the applications. Although this work is of theoretical 
nature and does not account for many technical details of group testing such as 
maximal group sizes and error types, a very conservative assessment of the tests 
that can be saved in this application is about two-thirds, which means that use of 
group testing is equivalent to a scaling up of test production by a factor of three 
or more.
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In this paper, we focused our attention to RT-PCR tests that are able to detect 
infection. Alternatively, serological tests are used to detect the presence of 
antibodies, thus the immunity of the individual. In the absence of a vaccine, it 
is an urgent strategic issue to detect immunity in the most essential professions, 
and group testing should also be used for this purpose.
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